Inventor

NAKAMURA MIKIKO

JP9 patents

⚠️ This page may combine multiple inventors who share the name “NAKAMURA MIKIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENEFRONTIER CORP

3 patents

US12565517B2Mar 3, 2026

Cyclic peptide having CTLA-4 inhibitory activity and use thereof

GENEFRONTIER CORP0 citations57

US10865247B2Dec 15, 2020

Anti-human CD69 antibody, and use thereof for medical purposes

GENEFRONTIER CORP0 citations45

US9617533B2Apr 11, 2017

Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said composition

GENEFRONTIER CORP0 citations45

AKADA RINJI

2 patents

US8633029B2Jan 21, 2014

Agent for improving gene transfer efficiency to mammalian cells

AKADA RINJI6 citations79

US9796973B2Oct 24, 2017

Terminator sequence-containing reverse primer for overexpression and linear DNA

AKADA RINJI1 citations47

CHUGAI PHARMACEUTICAL CO LTD

1 patent

US10782300B2Sep 22, 2020

GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy

CHUGAI PHARMACEUTICAL CO LTD4 citations72

UNIV KEIO

1 patent

US10640573B2May 5, 2020

Human antibody against aggrecanase-type ADAMTS species for therapeutics of aggrecanase-related diseases

UNIV KEIO0 citations48

KANAMORI TAKASHI

1 patent

US9175327B2Nov 3, 2015

Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said composition

KANAMORI TAKASHI0 citations45

KOJOH KANEHISA

1 patent

US9493523B2Nov 15, 2016

RNF8-FHA domain-modified protein and method of producing the same

KOJOH KANEHISA1 citations42